Fujii Masazumi, Ichikawa Masahiro, Iwatate Kensho, Bakhit Mudathir, Yamada Masayuki, Kuromi Yosuke, Sato Taku, Sakuma Jun, Sato Hisashi, Kikuta Atsushi, Suzuki Yoshiyuki, Saito Kiyoshi
Department of Neurosurgery, Fukushima Medical University, Fukushima prefecture, Fukushima City, Japan.
Department of Radiation Oncology, Fukushima Medical University, Fukushima prefecture, Fukushima City, Japan.
Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):245-249. doi: 10.1016/j.rpor.2020.01.009. Epub 2020 Jan 30.
To study the probability of developing secondary brain tumors after cranial radiotherapy.Background Patients treated with cranial radiotherapy are at risk for developing secondary brain tumors.
We planned an institutional survey for secondary brain tumors in survivors after cranial irradiation and reviewed the 30-year duration data. Event analysis and cumulative proportion curves were performed to generally estimate the cumulative proportion of developing secondary brain tumors, cavernoma and meningioma at different periods of time.
Secondary brain tumors occurred in 21% of cases: 10% were cavernomas, 6% were meningiomas, 3% were skull osteomas, and 1% were anaplastic astrocytoma. The cumulative proportion of developing secondary brain tumor was 6% at 10 years and 20% at 20 years, while the cumulative proportion for developing cavernomas and meningiomas was 16% and 7% at 20 years, respectively.
Our study shows that patients who received cranial irradiation were at risk of secondary brain tumors such as cavernomas and meningiomas. Thus, a meticulous follow-up of cancer survivors with history of cranial irradiation by an annual MRI scan is justifiable. This will help clinicians to detect secondary brain tumors early and make its management much easier.
研究颅脑放疗后发生继发性脑肿瘤的概率。背景:接受颅脑放疗的患者有发生继发性脑肿瘤的风险。
我们计划对颅脑照射后幸存者中的继发性脑肿瘤进行一项机构性调查,并回顾了30年的数据。进行事件分析和累积比例曲线分析,以大致估计在不同时间段发生继发性脑肿瘤、海绵状血管瘤和脑膜瘤的累积比例。
21%的病例发生了继发性脑肿瘤:10%为海绵状血管瘤,6%为脑膜瘤,3%为颅骨骨瘤,1%为间变性星形细胞瘤。发生继发性脑肿瘤的累积比例在10年时为6%,在20年时为20%,而发生海绵状血管瘤和脑膜瘤的累积比例在20年时分别为16%和7%。
我们的研究表明,接受颅脑照射的患者有发生海绵状血管瘤和脑膜瘤等继发性脑肿瘤的风险。因此,对有颅脑照射史的癌症幸存者每年进行一次MRI扫描进行细致的随访是合理的。这将有助于临床医生早期发现继发性脑肿瘤并使其治疗更加容易。